Quantcast

Latest Cancer Stories

2014-07-16 23:08:14

Researchers say pemetrexed (Alimta), the top chemotherapy drug for mesothelioma, may carry a risk of acute kidney injury, even in patients whose baseline kidney function falls within recommended limits. Raleigh, NC (PRWEB) July 16, 2014 Italian scientists say patients on the popular mesothelioma drug pemetrexed may need to take certain precautions to avoid damaging their kidneys. An article on the new research has just been published on the Surviving Mesothelioma website. Click here to...

2014-07-16 23:07:15

The seven-year survivor has been working at ESPN since 1993 Austin, Texas (PRWEB) July 16, 2014 ESPN icon Stuart Scott will be presented with the Jimmy V Perseverance Award at tonight’s ESPYs for showing a positive attitude, persistence and determination in the face of a great obstacle – a seven-year battle with appendiceal cancer. Scott, who has been a beacon of strength in the face of cancer, epitomizes the LIVESTRONG Foundation’s ethos that attitude is everything. LIVESTRONG is...

2014-07-16 12:42:09

University of North Carolina Health Care UNC researchers lay the groundwork for a new approach to brain cancer treatments and a better understanding of Parkinson's disease Researchers at the UNC School of Medicine have discovered that the protein PARC/CUL9 helps neurons and brain cancer cells override the biochemical mechanisms that lead to cell death in most other cells. In neurons, long-term survival allows for proper brain function as we age. In brain cancer cells, though, long-term...

2014-07-16 08:27:11

OXFORD, England and INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Immunocore Limited today announced they have entered into a co-discovery and co-development collaboration to research and potentially develop novel T cell-based cancer therapies. Using Immunocore's Immune Mobilising Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology, the companies will seek to use the power of the body's own immune system to attack cancer cells. ImmTACs...

2014-07-16 04:21:39

TUEBINGEN, Germany, July 16, 2014 /PRNewswire/ -- Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics' Human Immunopeptidome Program to identify the most relevant targets for cancer immunotherapies immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company leading the development of advanced immunotherapies that are active against cancer, today announces that it has...

2014-07-15 23:14:44

Targeted therapy for pancreatic cancer is based on personalized medicine approach Somerville, Massachusetts (PRWEB) July 15, 2014 ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for cancer announced today that Tozaride, the Company's lead candidate, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for the treatment of pancreatic cancer. Pancreatic cancer is responsible for significant cancer...

2014-07-15 23:11:18

In CHAMPS Oncology's most recent blog post, Taking the CTR Exam? Best of Luck, Rhonda Spoden shares her thoughts on the topic. Cleveland, Ohio (PRWEB) July 15, 2014 In CHAMPS Oncology's most recent blog post, Taking the CTR Exam? Best of Luck, Rhonda Spoden shares her thoughts on the topic. Three times a year, The National Cancer Registrars Association (NCRA) offers a testing window for cancer registrars and other cancer data specialists to become Certified Tumor Registrars...

2014-07-15 16:27:17

Event helps researchers use Varian's non-clinical research tools to open up new horizons in cancer treatment technology AUSTIN, Texas, July 15, 2014 /PRNewswire/ -- Over 140 medical technology researchers from nine countries are slated to participate in the second annual Varian Medical Systems Developer Workshop, taking place here July 17-18, prior to the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM). Modeled after developers' conferences commonly...

2014-07-15 14:06:51

University of Texas M. D. Anderson Cancer Center Wide variations seen in up-front therapy versus active surveillance New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type of treatment they receive as a result. The findings, published in JAMA Internal Medicine, sought to examine why active...

2014-07-15 12:42:23

St. Michael's Hospital Ontario spent nearly $110 million dollars between 2006 and 2010 on bonuses to motivate family doctors to screen more of their patients for cancer but these bonuses were associated with little or no improvement in actual cancer screening rates, according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study, published today in Annals of Family Medicine, tracked screening rates for cervical, breast and...


Latest Cancer Reference Libraries

British Journal of Cancer
2012-05-28 10:11:32

The British Journal of Cancer (BJC) is a professional medical journal published biweekly by the Nature Publishing Group (a division of Macmillan Publishers Ltd.) on behalf of Cancer Research UK. It provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival. Papers are published both in print and online. The journal publishes full research papers and...

45_16476fe85b6c94ca2cddefe0d4dea632
2011-02-17 16:45:25

Merkel cell polyomavirus (MCV or MCPyV), first discovered in January 2008, is one of seven human tumor viruses. It is suspected to cause most of Merkel cell carcinoma which is a rare, aggressive form of skin cancer. Around 80% of Merkel cell carcinoma tumors are found to be infected with MCV. It is found in respiratory secretions suggesting that it may be transmitted by a respiratory route. Usually the tumors with MCV viruses go through at least two mutations that render the virus...

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

28_2d79dc61ecefd3449819abf298f2554d
2005-05-26 12:16:31

Asbestos (Greek a-, "not"; sbestos, "extinguishable") is a group of fibrous metamorphic minerals. The name is derived for its historical use in lamp wicks; the resistance of asbestos to fire has long been exploited for a variety of purposes. It was used in fabrics such as Egyptian burial cloths and Charlemagne's tablecloth, which, according to legend, he threw in a fire to clean. When asbestos is used for its resistance to fire or heat, the fibers are typically mixed with cement or woven...

3_ee7b9bf5a8a73941accea20822106ac22
2004-10-19 04:45:40

Cancer Constellation -- The constellation Cancer, the crab, is known in astronomy and astrology as one of the twelve constellations of the zodiac. Cancer is small and dim, and does not resemble a crab. It lies between Gemini to the west and Leo to the east, Lynx to the north and Canis Minor and Hydra to the south. Notable features The brightest star in Cancer is β Cancri, called Al Tarf ("the end" of the crab's leg). Other stars include Acubens (α), and the Aselli (the...

More Articles (5 articles) »
Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related